Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review

ABSTRACT: Background. Policies mandating the use of lower cost biosimilars in

SUBMITTER:  

PROVIDER: S-EPMC9969457 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature